Envestnet Portfolio Solutions’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.28M Sell
171,479
-3,830
-2% -$213K 0.05% 201
2025
Q4
$9.82M Buy
175,309
+3,379
+2% +$175K 0.03% 241
2025
Q3
$8.24M Buy
171,930
+10,842
+7% +$485K 0.03% 258
2025
Q2
$6.54M Buy
161,088
+47,626
+42% +$1.91M 0.02% 298
2025
Q1
$4.97M Sell
113,462
-1,040
-0.9% -$45.9K 0.02% 364
2024
Q4
$4.92M Buy
114,502
+49,766
+77% +$2.26M 0.02% 399
2024
Q3
$2.87M Buy
64,736
+6,203
+11% +$266K 0.01% 553
2024
Q2
$2.33M Buy
58,533
+1,510
+3% +$61.2K 0.01% 589
2024
Q1
$2.46M Buy
57,023
+10,534
+23% +$454K 0.01% 572
2023
Q4
$1.93M Sell
46,489
-2,273
-5% -$86.1K 0.01% 605
2023
Q3
$1.94M Buy
+48,762
New +$2.06M 0.01% 551

Other funds holding XPH